Sign inJoin waitlistJoin the waitlist

Heather Jacene

Associate Program Director, Brigham and Women's Joint Program in Nuclear Medicine · Mass General Brigham

Credentials: · · · ·

History

Brigham and Women's Joint Program in Nuclear Medicine · Mass General Brigham
Present
Nuclear Medicine/PET-CT · Mass General Brigham
Present
Mass General Brigham
Present

Nuclear Medicine
Johns Hopkins University School of Medicine
2001–2004
Robert Wood Johnson Medical School
1997–2001

Research

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors
Review · Journal of Nuclear Medicine · 2009 · 3,008 citations
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
New England Journal of Medicine · 2017 · 2,601 citations
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
Review · Blood · 2016 · 397 citations

Richard Wahl
32 papers
Christopher Sakellis
16 papers
Praful Ravi
16 papers
AA
Annick Van den Abbeele
12 papers
BO
Beth Overmoyer
12 papers
HS
Hina Shah
12 papers
Atish Choudhury
9 papers
EY
Eren Yeh
9 papers
Faina Nakhlis
9 papers
JB
Jennifer Bellon
8 papers
MR
Matthew Robertson
7 papers
Philippe Armand
7 papers

Clinical trials

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
Principal investigator · Active not recruiting · Phase 4
Brigham and Women's Hospital
2024–2027
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
Principal investigator · Recruiting · Phase 4
Brigham and Women's Hospital
2024–2026
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Principal investigator · Recruiting · Phase 1
Brigham and Women's Hospital
2024–2028
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Principal investigator · Active not recruiting · Phase 2
ECOG-ACRIN Cancer Research Group
2023–2029